Please Wait.....
Report
In-Vitro Diagnostic Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product & Service (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation and Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), End User (Hospitals, Laboratories, Home Care, and Others), and Geography (North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America)
Market Report I 2023-09-18 I 210 Pages I The Insight Partners
The in-vitro diagnostics market is expected to grow from US$ 72,393.80 million in 2022 to US$ 1,12,103.51 million by 2030; it is expected to grow at a CAGR of 5.6% from 2022 to 2030. The increasing prevalence of chronic diseases, technological advancements, and the growing geriatric population are the noteworthy factors driving the in-vitro diagnostics market growth.
In vitro diagnostics (IVD) are tests done on samples such as blood or tissues that have been taken from the human body. In-vitro diagnostics are specialized to detect diseases or other conditions that can be used to monitor a person's overall health to help cure, treat, or prevent diseases. Additionally, in-vitro diagnostics may also be utilized for precision medicine to identify patients who are likely to benefit from specific treatments or therapies. Therefore, these in-vitro diagnostics can include next-generation sequencing tests that scan a person's DNA to detect genomic variations.
Increasing Prevalence of Chronic and Infectious Diseases
The world is witnessing an exponential increase in the prevalence of infectious diseases. These diseases are prominently caused due to pathogenic microorganisms, such as viruses, bacteria, and parasites. Factors such as poor sanitary conditions, lack of public hygiene, elevating levels of air pollution, and unavailability of safe drinking water play a significant role in the bolstering prevalence of infectious diseases. According to the Public Health Agency of Canada, the country reported a total of 6,736 cases of hepatitis C (acute, chronic, and unspecified combined) in 2020.
Chronic diseases prominently include cancer, chronic respiratory diseases, diabetes, and heart disease. The incidences of these conditions are skyrocketing globally due to biological risk factors, such as an increase in alcohol and tobacco consumption, adoption of unhealthy diets, lack of physical activity, and prevalence of obesity. Chronic conditions are the leading cause of mortality globally. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as stroke, cancer, heart disease, or diabetes. These chronic diseases are the leading causes of death and disabilities, and burgeoning healthcare costs in the US; the country's healthcare cost was ~US$ 4.1 trillion in 2021. The CDC data also suggests that heart disease is the leading cause of death among men, women, and people of most racial and ethnic groups.
According to CDC data, coronary artery disease (CAD) is the most common cause of mortality among adults. Approximately 375,476 people died due to CAD in 2021. Estimates published in the 2022 National Diabetes Statistics Report by the World Health Organization state that ~422 million people worldwide have diabetes, the majority living in low-and middle-income countries. Moreover, 1.5 million deaths are directly related to diabetes each year. overweight, genetic conditions, aging, sedentary lifestyle, etc., are boosting the prevalence of diabetes. According to estimations published in a Cancer Research UK report, ~18.1 million new cancer cases were reported in the world in 2020, and the number is expected to increase to 28 million by 2040. Hence, the rising prevalence of infectious and chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory conditions drives the growth of the in-vitro diagnostics market.
Market Trend
Increasing Demand for Personalized Medicine and Genomics
North America is at the forefront of personalized medicine and genomics research. There is increasing integration of genomics and molecular diagnostics into routine patient care. Companies are involved in developing advanced genetics hold substantial opportunities for the in-vitro diagnostics market. North America, particularly the US and Canada, has been a hub for genomic research centers that contribute notably to understanding and knowledge on the genetic basis of diseases, identification of biomarkers, and development of targeted therapies. Both these countries have launched precision medicine initiatives to integrate genomics into clinical practices. North America has been a leader in cancer genomics, hosting extensive research and clinical trials focused on understanding the genetic factors associated with different types of cancer. These trials aim to evaluate the efficacy of targeted therapies, immunotherapies, and other innovative treatments based on the genetic characteristics of patients' tumors. The American Cancer Society estimates that the US would record 1.9 million new cancer cases (~5,370 cases per day) and 609,820 deaths from cancer in 2023. With such a high incidence, there is a pressing need for effective treatment to improve the quality of life of these patients.
Personalized medicine involves running in-vitro diagnostics tests on patients to stratify them into subgroups based on their unique characteristics. The field of personalized medicine, along with advancements in genomics sequencing, molecular profiling, and other diagnostic technologies, has the potential to revolutionize healthcare by providing targeted, precise, and individualized treatment approaches. Genetics have become increasingly accessible globally. In November 2022, Roche, Cancer Research UK, and the University of Manchester announced the launch of a multidrug, precision medicine DETERMINE trial. The trial seeks to evaluated if available agents, including those that are licensed for more common cancer types, could benefit patients with rare cancer types. The trial recruited both adult and pediatric patients with rare cancer types. Companies such as 23and Me and AncestryDNA offer direct-to-consumer genetic testing kits, allowing individuals to gain insights into their ancestry, genetic traits, and potential health risks. Healthcare providers also offer genetic testing to guide treatment decisions. Thus, the demand for personalized medicine and genomics will propel the growth of the in-vitro diagnostics market during the forecast period.
The "Global In-Vitro Diagnostic Market" is segmented on the basis of product and service, application, technology, end user, and geography. Based on product and service, the market is segmented into reagents and kits, instruments, and software and services. In 2022, the reagents and kits segment held the largest share of the market. The projected growth of the market for reagents and kits is attributed to the tremendous popularity of self-test kits and POC devices, and a rise in availability and adoption automated instruments that simplify jobs and provide accurate results. The increasing cases of viral and fungal infections with inadequate hygienic conditions promote reagent use. Thus, players in the in-vitro diagnostics market are offering superior quality molecular reagents and kits for better patient management and care.
European Medicines Agency, Emergency Use Authorization, Centers for Disease Control and Prevention, International Diabetes Federation, In-Vitro Diagnostic Research are some of the relevant sources referred while preparing the in-vitro diagnostics market research report.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 In-Vitro Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In-Vitro Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 PEST Analysis
5. In-Vitro Diagnostics Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
5.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraint
5.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
5.3 Market Opportunities
5.3.1 Integration of IVD with Digital Health Technologies
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicine and Genomics
6. In-Vitro Diagnostics Market - Global Market Analysis
6.1 In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030
7. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services
7.1 Overview
7.2 In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Software and Services
7.4.1 Overview
7.4.2 Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Instruments
7.5.1 Overview
7.5.2 Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology
8.1 Overview
8.2 In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Immunoassay/ Immunochemistry
8.3.1 Overview
8.3.2 Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Chemistry
8.4.1 Overview
8.4.2 Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Molecular Diagnostics
8.5.1 Overview
8.5.2 Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Microbiology
8.6.1 Overview
8.6.2 Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Blood Glucose Self-Monitoring
8.7.1 Overview
8.7.2 Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Coagulation and Hemostasis
8.8.1 Overview
8.8.2 Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Hematology
8.9.1 Overview
8.9.2 Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Urinalysis
8.10.1 Overview
8.10.2 Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application
9.1 Overview
9.2 In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Cardiology
9.6.1 Overview
9.6.2 Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Autoimmune Diseases
9.7.1 Overview
9.7.2 Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Nephrology
9.8.1 Overview
9.8.2 Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. Global In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Laboratories
10.4.1 Overview
10.4.2 Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Homecare
10.5.1 Overview
10.5.2 Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis
11.1 North America: In-Vitro Diagnostics Market
11.1.1 Overview
11.1.2 North America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.7 North America: In-Vitro Diagnostics Market, by Country
11.1.7.1 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.1.7.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.7.1.5 US: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.1.7.1.6 US: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.7.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.1.7.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.7.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.1.7.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.7.3 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.1.7.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.7.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.1.7.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.2 Europe: In-Vitro Diagnostics Market
11.2.1 Overview
11.2.2 Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.2.4 Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.2.5 Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.2.6 Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.2.7 Europe: In-Vitro Diagnostics Market, by Country
11.2.7.1 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.3 Germany: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.2.7.1.4 Germany: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.2.7.1.5 Germany: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.2.7.1.6 Germany: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.2.7.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.3 France: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.2.7.2.4 France: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.2.7.2.5 France: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.2.7.2.6 France: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.2.7.3 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.3 UK: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.2.7.3.4 UK: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.2.7.3.5 UK: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.2.7.3.6 UK: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.2.7.4 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.3 Italy: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.2.7.4.4 Italy: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.2.7.4.5 Italy: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.2.7.4.6 Italy: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.2.7.5 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.3 Spain: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.2.7.5.4 Spain: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.2.7.5.5 Spain: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.2.7.5.6 Spain: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.2.7.6 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.3 Rest of Europe: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.2.7.6.4 Rest of Europe: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.2.7.6.5 Rest of Europe: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.2.7.6.6 Rest of Europe: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.3 Asia Pacific: In-Vitro Diagnostics Market
11.3.1 Overview
11.3.2 Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.3.4 Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.3.5 Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.3.6 Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.3.7 Asia Pacific: In-Vitro Diagnostics Market, by Country
11.3.7.1 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.3 China: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.3.7.1.4 China: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.3.7.1.5 China: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.3.7.1.6 China: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.3.7.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.3 Japan: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.3.7.2.4 Japan: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.3.7.2.5 Japan: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.3.7.2.6 Japan: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.3.7.3 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.3 India: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.3.7.3.4 India: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.3.7.3.5 India: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.3.7.3.6 India: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.3.7.4 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.3 Australia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.3.7.4.4 Australia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.3.7.4.5 Australia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.3.7.4.6 Australia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.3.7.5 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.3 South Korea: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.3.7.5.4 South Korea: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.3.7.5.5 South Korea: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.3.7.5.6 South Korea: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.3.7.6 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.4 Middle East & Africa: In-Vitro Diagnostics Market
11.4.1 Overview
11.4.2 Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.4.4 Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.4.5 Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.4.6 Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.4.7 Middle East & Africa: In-Vitro Diagnostics Market, by Country
11.4.7.1 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.3 South Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.4.7.1.4 South Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.4.7.1.5 South Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.4.7.1.6 South Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.4.7.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.3 Saudi Arabia: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.4.7.2.4 Saudi Arabia: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.4.7.2.5 Saudi Arabia: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.4.7.2.6 Saudi Arabia: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.4.7.3 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.3 UAE: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.4.7.3.4 UAE: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.4.7.3.5 UAE: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.4.7.3.6 UAE: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.4.7.4.6 Rest of Middle East & Africa: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.5 South & Central America: In-Vitro Diagnostics Market
11.5.1 Overview
11.5.2 South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.5.4 South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.5.5 South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.5.6 South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.5.7 South & Central America: In-Vitro Diagnostics Market, by Country
11.5.7.1 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.3 Brazil: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.5.7.1.4 Brazil: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.5.7.1.5 Brazil: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.5.7.1.6 Brazil: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.5.7.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.3 Argentina: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.5.7.2.4 Argentina: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.5.7.2.5 Argentina: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.5.7.2.6 Argentina: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.5.7.3 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.3 Rest of South & Central America: In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
11.5.7.3.4 Rest of South & Central America: In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.5.7.3.5 Rest of South & Central America: In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
11.5.7.3.6 Rest of South & Central America: In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in North America In-Vitro Diagnostics Market
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Danaher Corp
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Siemens AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sysmex Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Becton Dickinson and Co
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio-Rad Laboratories Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Qiagen NV
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. In-Vitro Diagnostics Market Segmentation
Table 2. North America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. North America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. US In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. US In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 8. US In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 9. US In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Europe In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 20. Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 21. Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Germany In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Germany In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Germany In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Germany In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. France In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 27. France In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 28. France In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 29. France In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 30. UK In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 31. UK In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 32. UK In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 33. UK In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. Italy In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 35. Italy In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 37. Italy In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 38. Spain In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 39. Spain In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 41. Spain In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 42. Rest of Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 44. Rest of Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 45. Rest of Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 46. Asia Pacific In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 47. Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 48. Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 49. Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 50. Death Rate Of Cancer in 2020 Globally
Table 51. China In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 52. China In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 53. China In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 54. China In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 55. Japan In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 56. Japan In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 57. Japan In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 58. Japan In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 59. India In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 60. India In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 61. India In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 62. India In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 63. Australia In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 64. Australia In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 65. Australia In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 66. Australia In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 67. South Korea In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 68. South Korea In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 69. South Korea In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 70. South Korea In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 71. Rest of Asia Pacific In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 72. Rest of Asia Pacific In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 73. Rest of Asia Pacific In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 74. Rest of Asia Pacific In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 75. Middle East & Africa In-Vitro Diagnostics Market, For Reagents and Kits by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 76. Middle East & Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 77. Middle East & Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 78. Middle East & Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 79. South Africa In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 80. South Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 81. South Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 82. South Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 83. Saudi Arabia In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 84. Saudi Arabia In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 85. Saudi Arabia In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 86. Saudi Arabia In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 87. UAE In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 88. UAE In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 89. UAE In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 90. UAE In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 93. Rest of Middle East & Africa In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 94. Rest of Middle East & Africa In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 95. South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 96. South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 97. South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 98. Brazil In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 99. Brazil In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 100. Brazil In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 101. Brazil In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 102. Argentina In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 103. Argentina In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 104. Argentina In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 105. Argentina In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of South & Central America In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of South & Central America In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of South & Central America In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of South & Central America In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 110. Organic Developments Done by Companies
Table 111. Inorganic Developments Done by Companies
Table 112. Glossary of Terms, In-Vitro Diagnostics Market
LIST OF FIGURES
Figure 1. In-Vitro Diagnostics Market Segmentation, By Geography
Figure 2. PEST Analysis
Figure 3. In-Vitro Diagnostics Market: Key Industry Dynamics
Figure 4. In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 5. In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
Figure 6. Global In-Vitro Diagnostics Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 8. Reagents and Kits: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Software and Services: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Instruments: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 12. Immunoassay/ Immunochemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinical Chemistry: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Molecular Diagnostics: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Microbiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Blood Glucose Self-Monitoring: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Coagulation and Hemostasis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Hematology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Urinalysis: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
Figure 22. Infectious Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diabetes: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Oncology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Cardiology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Autoimmune Diseases: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Nephrology: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 30. Hospitals: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Laboratories: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Homecare: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Others: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. North America: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 35. North America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 36. North America: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 37. US: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 38. Canada: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 39. Mexico: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 40. Europe: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 41. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 42. Europe: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 43. Germany: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 44. France: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 45. UK: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 46. Italy: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 47. Spain: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 48. Rest of Europe: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 49. Asia Pacific: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 50. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. Asia Pacific: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 52. China: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. Japan: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. India: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 55. Australia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 56. South Korea: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 57. Rest of Asia Pacific: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 58. Middle East & Africa: In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 59. Middle East & Africa In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 60. Middle East & Africa: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 61. South Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 62. Saudi Arabia: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 63. UAE: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 64. Rest of Middle East & Africa: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 65. South & Central America: In-Vitro Diagnostics Market, By Key Country - Revenue (2022) (US$ Million)
Figure 66. South & Central America In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 67. South & Central America: In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 68. Brazil: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 69. Argentina: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 70. Rest of South & Central America: In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 71. Growth Strategies in North America In-Vitro Diagnostics Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security